ETF收評 | 港股創新藥板塊大肆回調,港股通創新藥ETF工銀、恆生創新藥ETF跌逾4%
A股三大指數今日集體上漲,截至收盤,滬指漲0.82%,深成指漲1.72%,創業板指漲2.63%,北證50指數漲2.89%。全市場成交額13409億元,較上日放量1185億元。全市場超4100只個股上漲。板塊題材上,軍工、機器人、蘋果產業鏈、軌交設備、光伏設備、固態電池板塊漲幅居前;貴金屬、農業、創新藥、電力、飲料製造板塊跌幅居前。ETF方面,招商基金中證2000增強ETF尾盤異動拉昇,收漲6.44%,最新溢折率爲4.34%。軍工板塊再度爆發,富國基金軍工龍頭ETF、鵬華基金國防ETF、嘉實基金高端裝備ETF分別漲5.53%、5.05%和5.01%。航天航空板塊跟隨上揚,萬家基金航天航空ETF漲4.29%。機器人板塊再度走高,景順長城基金機器人50ETF、機器人ETF易方達分別漲4.07%、4.05%。港股創新藥板塊大肆回調,港股通創新藥ETF工銀、恆生創新藥ETF和港股通創新藥ETF分別跌4.83%、4.51%和4.5%。金價下挫,黃金ETFAU、黃金ETF華夏均跌2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.